Chronic Pain Treatments
Find Chronic Pain Treatments
Medications for Chronic Pain
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Chronic Pain.
Found 4 Approved Drugs for Chronic Pain
OxyCODONE
Brand Names
Allzital, Ascomp, Butal, Butalbital, ConZip, Endocet, Fioricet, Homatropine Methylbromide, HYDROcodone, HYDROcodone APAP, Hysingla, Nalocet, Norco, Oxaydo, OxyContin, Percocet, Roxicodone, RoxyBond, Tencon, TraMADol, Xtampza
OxyCODONE
Brand Names
Allzital, Ascomp, Butal, Butalbital, ConZip, Endocet, Fioricet, Homatropine Methylbromide, HYDROcodone, HYDROcodone APAP, Hysingla, Nalocet, Norco, Oxaydo, OxyContin, Percocet, Roxicodone, RoxyBond, Tencon, TraMADol, Xtampza
Form: Liquid, Tablet, Capsule, Solution
Method of administration: Oral
FDA approval date: December 07, 1983
Classification: Opioid Agonist
Butalbital and Acetaminophen tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Symproic
Generic Name
Naldemedine
Symproic
Generic Name
Naldemedine
Form: Tablet
Method of administration: Oral
FDA approval date: June 14, 2019
Classification: Opioid Antagonist
SYMPROIC is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. SYMPROIC is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation ( 1 )
Movantik
Generic Name
Naloxegol
Movantik
Generic Name
Naloxegol
Form: Tablet
Method of administration: Oral
FDA approval date: October 01, 2020
Classification: Opioid Antagonist
MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation. MOVANTIK is an opioid antagonist indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
Prialt
Generic Name
Ziconotide Acetate
Prialt
Generic Name
Ziconotide Acetate
Form: Injection
Method of administration: Intrathecal
FDA approval date: October 15, 2018
Classification: N-type Calcium Channel Antagonist
PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine. PRIALT (ziconotide) solution, intrathecal infusion is an N-type calcium channel antagonist indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine. ( 1 )
Showing 1-4 of 4
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances